# Torrey Pines Medicine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/torrey-pines-medicine

- Industry: Pharmaceuticals
- Headquarters: Shenzhen, China
- Latest round: Angel (Jul 28, 2026)
- Investors on record: 4

## About

Based in Guangdong, China and founded in 2024, Torrey Pines Medicine (Shenzhen) Ltd., trading as Torrey Pines Medicine, is a peptide drug developer. In July 2026, Torrey Pines Medicine raised an angel funding led by Lotus Lake Capital, with participation from Star Capital, Taiyou, BOCG, and individual investor Shen Yousheng.

The company focuses on providing long-acting peptide drug development services for metabolic diseases such as obesity and diabetes. It utilizes artificial intelligence, high-throughput screening, and structural biology to accurately and efficiently discover and optimize drug candidate compounds, providing patients with innovative treatment options.

The company's revenue is generated by providing long-acting peptide drug development services for metabolic diseases such as obesity and diabetes.

The company will use the funding for the company's early-stage development, with a focus on advancing the IND application and Phase I clinical trial of the company's core pipeline TPM004, while further improving the PepTetris™ ultra-long-acting peptide platform and continuously empowering the development of early-stage innovative drug pipelines.

## Funding rounds

- Angel, Jul 28, 2026 — Lotus Lake Capital, Taiyou, Star Capital, BOCG

## Investors

- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Angel
- Taiyou (https://capitalatlas.ai/funds/taiyou) — Angel
- Star Capital — Angel
- BOCG (https://capitalatlas.ai/funds/bocg) — Angel